Revive Therapeutics proposes issuing 1,221,516 shares at $0.05 to settle $61,061 debt
Reuters2026/08/19 18:35Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Revive Therapeutics proposed settling trade payables of $61,061 by issuing up to 1,221,516 common shares.
- Settlement shares priced at $0.05 each; creditors described as arm’s length.
- Closing expected no earlier than five business days; subject to Canadian Securities Exchange acceptance.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revive Therapeutics Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608191435ACCESSWRNAPR_____1209358) on August 19, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Mondelez declares Q3 2026 distribution of R$ 0.3 per unit, payable Oct. 20
Reuters•2026/08/19 19:34
CENIT completes rights issue, raising about EUR 10.9 million
Reuters•2026/08/19 19:34
RGC Resources director Robert B. Johnston buys $17,157 of common shares
Reuters•2026/08/19 19:34
Abbott Laboratories announces dividend of R$ 0.18 per unit for 3Q 2026
Reuters•2026/08/19 19:33